Perkins Coie Trust Co decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,377 shares of the exchange traded fund’s stock after selling 371 shares during the period. Perkins Coie Trust Co’s holdings in SPDR S&P Biotech ETF were worth $574,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Tidemark LLC raised its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $40,000. ORG Wealth Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $44,000. Howe & Rusling Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $49,000. Finally, Waldron Private Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $54,000.
SPDR S&P Biotech ETF Trading Up 0.1 %
NYSEARCA XBI opened at $87.97 on Friday. The business has a fifty day simple moving average of $94.09 and a 200 day simple moving average of $96.94. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The firm has a market capitalization of $6.71 billion, a P/E ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- What is the NASDAQ Stock Exchange?
- Oilfield Leader SLB: An AI Name You Need to Know
- What Are Earnings Reports?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.